TAG:
diagnostic laboratories
Paper Requisition Signature Rule Contradicts 2001 Actions
By Robert Michel | From the Volume XVIII No. 1 – January 18, 2011 Issue
CEO SUMMARY: Last year, the Centers for Medicare and Medicaid Services (CMS) used publication of the proposed 2011 Medicare Physician Fee Schedule to introduce new language that would require, as of January 1, 2011, that all paper requisitions for clinical laboratory tests for Me…
September 17, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 13 – September 17, 2007 Issue
Coming soon to a theater near you this fall is the movie Pathology, with Rutger Hauer in the starring role as a pathologist. The Internet Movie database says Pathology (www.enterpathologylab.com) is the story of how medical students decide which of them can commit the perfect murder without being det…
Review of 2004 Lab Sales Identifies Buyer Interest
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase p…
Five Lab Acquisitions Over the Past Ten Weeks
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Many lab executives and pathologists will be surprised to learn that five independent laboratory companies were acquired between December 1, 2004 and February 11, 2005. Only one acquisition was announced to the public. The other four were private sales and both buyers and sel…
“State of Industry” Report On Molecular Diagnostics
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
CEO SUMMARY: Enterprise Analysis Corporation has launched an ambitious survey that will include 150 laboratories performing molecular testing in the United States. Last week it released information about the first 51 labs contacted in this effort. The survey provides an intriguing look at…
Laboratories Sit Squarely Between New Genetics and Today’s Medicine
By Robert Michel | From the Volume IX No. 18 – December 30, 2002 Issue
“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson. CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary…
“February 18, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
Lab execs and pathologists should pay close attention to this fact: Internet use by Americans significantly increased again last year. The Commerce Department reported that. as of September, 143 million people in the U.S. were using the Internet. This is 54% of the population and rep…
Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has in…
“Disease Management” Firms, Niche Labs Release Financials
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
Two DISEASE MANAGEMENT FIRMS enjoyed strong revenue growth during the first quarter of 1998. UroCor, Inc. and Impath Inc. posted revenue increases of 31% and 49%, respectively, over first quarter 1997. UroCor is the disease management company which serves urologists…
“January 6, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 1 – January 6, 1997 Issue
Interesting bedfellows have come together in Pittsburgh. The University of Pittsburgh Medical Center (UPMC) and Quest Diagnostics Incorporated (formerly Corning Clinical Laboratories) announced an agreement to “explore joint ventures in laboratory …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized